The emergence of carbapenem- and colistin-resistant Enterobacterales mediated by transmissible plasmids poses a critical One Health threat by compromising the efficacy of last-resort antimicrobials. We characterized a commensal Escherichia coli ST156 isolate recovered from a clinically healthy companion dog in South Korea that carried bla NDM-5 and mcr-1 on distinct plasmids. Antimicrobial susceptibility testing revealed a multidrug-resistant phenotype, including resistance to carbapenems (imipenem MIC, ≥8 μg/mL) and colistin (MIC, 8 μg/mL). Hybrid long- and short-read genome assembly localized bla NDM-5 to an IncX3 plasmid and mcr-1 to an IncX4 plasmid. Broth-mating assays showed that each plasmid was independently transferable under the corresponding single-antimicrobial selection. Among 30 transconjugant colonies screened under each selection, both resistance determinants were detected in five colistin-selected and two meropenem-selected colonies, indicating co-detection of both resistance determinants in a minority of the screened colonies. Comparative genomic analysis showed that the IncX4- mcr-1 plasmid shared a highly conserved backbone with globally distributed IncX4 plasmids from diverse sources. These findings demonstrate asymptomatic carriage of independently transferable carbapenem- and colistin-resistance plasmids in a companion animal and support the inclusion of companion animals in integrated antimicrobial resistance surveillance.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: